Skip to main content

Table 1 Summary of the number of metabolic features that show statistically significant differences (P < 0.05) in each group comparison for each independent study and the number of features that are statistically significant in both independent studies

From: Metabolomic analysis of rat serum in streptozotocin-induced diabetes and after treatment with oral triethylenetetramine (TETA)

Comparison Study 1 (P< 0.05) Study 2 (P< 0.05) Both studies (P< 0.05)
Non-diabetic/TETA-treated rats versus non-diabetic/untreated rats 234 211 5
Non-diabetic/TETA-treated rats versus STZ-induced diabetic/TETA-treated rats 1,129 3,077 576
Non-diabetic/TETA-treated rats versus STZ-induced diabetic/untreated rats 1,310 2,943 623
Non-diabetic/untreated rats versus STZ-induced diabetic/TETA-treated rats 1,480 3,308 768
Non-diabetic/untreated rats versus STZ-induced diabetic/untreated rats 1,677 2,982 791
STZ-induced diabetic/TETA-treated rats versus STZ-induced diabetic/untreated rats 145 406 12
  1. STZ, streptozotocin; TETA, triethylenetetramine.